نتائج البحث - "Robert Z. Orlowski"

1

Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM

المصدر: Blood Adv

مصطلحات موضوعية: Melphalan, Oncology, medicine.medical_specialty, Transplantation Conditioning, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Transplantation, Autologous, Autologous stem-cell transplantation, Internal medicine, Commentary, medicine, business, Busulfan, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb49668a408811d17398ce1af6bc922Test
https://doi.org/10.1182/bloodadvances.2020002590Test

2

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

المؤلفون: Jeffrey A. Zonder, Edward S. Peters, Xin Sheng, Nalini Janakiraman, Frits van Rhee, John D. Carpten, Jennifer J. Hu, Mark A. Fiala, Sagar Lonial, W. Ryan Diver, Wei Zheng, Christopher A. Haiman, Antoinette M. Stroup, Leon Bernal-Mizrachi, William J. Blot, Barbara Nemesure, Loic Le Marchand, Graham A. Colditz, David Van Den Berg, Robert Z. Orlowski, Lisa B. Signorello, Phyllis J. Goodman, Benjamin A. Rybicki, Laurence N. Kolonel, Elad Ziv, Rick A. Kittles, Victor Hom, Howard R. Terebelo, Ajay K. Nooka, Seema Singhal, Thomas G. Martin, Cathryn H. Bock, Brian C.-H. Chiu, Sue A. Ingles, Sarah J. Nyante, Carol Ann Huff, Ann Mohrbacher, Eric A. Klein, Maurizio Zangari, Kristin A. Rand, Michael F. Press, Zhaohui Du, Karen Pawlish, Niels Weinhold, Michael H. Tomasson, Owen W. Stephens, Janet L. Stanford, Ravi Vij, Daniel Auclair, Jayesh Mehta, Daniel O. Stram, Anselm Hennis, Alexander Stram, Gareth J. Morgan, David V. Conti, Jeffrey L. Wolf, Andrew F. Olshan, Esther M. John, Leslie Bernstein, Sonja I. Berndt, Stephen J. Chanock, Gregory Song, Amie E. Hwang, Wendy Cozen, Sikander Ailawadhi, Kenneth C. Anderson, Victoria L. Stevens, Graham Casey, Regina G. Ziegler, John S. Witte

المصدر: Blood advances, vol 4, iss 1

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Clinical Trials and Observations, Genetic admixture, Single-nucleotide polymorphism, Genome-wide association study, Biology, Polymorphism, Single Nucleotide, 03 medical and health sciences, Rare Diseases, 0302 clinical medicine, Clinical Research, Internal medicine, Genetic variation, Genetics, medicine, Humans, 2.1 Biological and endogenous factors, Genetic Predisposition to Disease, Polymorphism, Aetiology, Allele, Cancer, Genetic association, Prevention, Human Genome, Single Nucleotide, Hematology, Confidence interval, 030104 developmental biology, Genetic Loci, 030220 oncology & carcinogenesis, Meta-analysis, Female, Transcriptional Elongation Factors, Multiple Myeloma, Genome-Wide Association Study

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::688d63748ff746a83c5c8c8381866045Test
https://doi.org/10.1182/bloodadvances.2019000491Test

3

Updated Analysis of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): The Phase 3 Maia Study

المصدر: Kumar, S K, Facon, T, Usmani, S Z, Plesner, T, Orlowski, R Z, Touzeau, C, Basu, S, Bahlis, N J, Goldschmidt, H, O'Dwyer, M E, Venner, C P, Weisel, K, Hulin, C, Karlin, L, Preis, M, Broyl, A, Renwick, W, Hansson, M, Krevvata, M, Wang, J, Van Rampelbergh, R, Ukropec, J, Uhlar, C M, Kobos, R & Perrot, A 2020, ' Updated Analysis of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) : The Phase 3 Maia Study ', Blood, vol. 136, no. Suppl. 1, pp. 24-26 . https://doi.org/10.1182/blood-2020-134847Test

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Daratumumab, Cell Biology, Hematology, Newly diagnosed, medicine.disease, Biochemistry, Transplant ineligible, Internal medicine, medicine, In patient, business, Multiple myeloma, Dexamethasone, Lenalidomide, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5896bbe9c1a891d488ec422553d253f1Test
https://doi.org/10.1182/blood-2020-134847Test

4

Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Post-Transplant Myeloma Patients

المؤلفون: Elisabet E. Manasanch, Donna M. Weber, Muzaffar H. Qazilbash, Robert Z. Orlowski, Krina K. Patel, Hans C. Lee, Qaiser Bashir, Jatin J. Shah, Sheeba K. Thomas, Ashley Morphey, Jasper B. Olsem, Xiao Jiao Huo, Lei Feng

المصدر: Blood. 138:4774-4774

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Cell Biology, Hematology, Biochemistry, Post transplant, Ixazomib, chemistry.chemical_compound, chemistry, Maintenance therapy, Internal medicine, medicine, business, Lenalidomide, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::27933ea36fdd6163d379be57f228e1fcTest
https://doi.org/10.1182/blood-2021-151950Test

5

Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial

المصدر: Perrot, A, Facon, T, Kumar, S, Plesner, T, Orlowski, R Z, Moreau, P, Bahlis, N J, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, M E, Venner, C P, Weisel, K, Mace, J R, Raje, N S, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Liu, K, Fastenau, J, Gries, K S, Ho, K F, Mistry, P, Tromp, B, Delioukina, M, Vermeulen, J & Usmani, S Z 2021, ' Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone : Update of the Phase 3 MAIA Trial ', Blood, vol. 138, no. Suppl. 1, 1655 . https://doi.org/10.1182/blood-2021-144421Test

مصطلحات موضوعية: Health related quality of life, Oncology, medicine.medical_specialty, business.industry, Immunology, Daratumumab, Cell Biology, Hematology, Newly diagnosed, medicine.disease, Biochemistry, Transplant ineligible, Internal medicine, Medicine, business, Multiple myeloma, Dexamethasone, Lenalidomide, medicine.drug